Welcome to the ValueWiki Biovest International, Inc. (BVTI) article! Register for free or click the "edit" link to contribute!

Biovest International, Inc. (BVTI)

This summary section needs content! Click Here to begin writing.

Have a question about Biovest International, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

12/01/08 5:12 pm	BIOVEST INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
11/26/08 7:11 am	Accentia reorganization claims more jobs (at bizjournals.com)
11/14/08 5:11 pm	BIOVEST INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (EDGAR Online)
11/11/08 2:11 am	Accentia, Biovest file for bankruptcy (at bizjournals.com)
11/10/08 3:11 pm	BIOVEST INTERNATIONAL INC Files SEC form 8-K, Bankruptcy or Receivership, Financial Statements and Exhibits (EDGAR Online)
11/10/08 11:11 am	Biovest International Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize its Drugs and Technologies (Business Wire)
10/31/08 4:10 pm	BIOVEST INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ (EDGAR Online)
10/29/08 11:10 am	Biovest plans cancer drug sales in Europe (at bizjournals.com)
10/29/08 11:10 am	BIOVEST INTERNATIONAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
10/29/08 8:10 am	Biovest and IDIS Announce Agreement to Launch Named-Patient Program for Anti-Cancer Vaccine in Europe (Business Wire)